of non-CABG patients, and 4.7% of PCI patients. Intracranial hemorrhage occurred in one patient. Vascular access site bleeding occurred in 0.4% of all patients and in 1.5% of PCI patients. Increased age, lower weight, ST deviation, positive troponin status, an early invasive strategy, angiography during the initial hospitalization. emergent PCI, and CABG were all associated with major bleeding in univariate analysis. Only CABG and Age ~65 were independently associated with major bleeding in the multivariate analysis.
After adjustment for CABG, age>65, positive troponin status, diabetes, and ST deviation, major bleeding was independently associated with an increased risk of death at 30 days (OR 5.0, p<O.OOi). Major bleeding was associated with $6,596 per patient of excess initial hospitalization costs, and 1.2 days per patient increase in length of stay (after adjustment for potential confounding variables).
Conclusions:
Major bleeding occurred infrequently despite a high rate of invasive revascularization procedures.
Major bleeding is associated with excess costs, increased length of stay, and higher mortality.
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Renal Insufficiency in the Setting of an Acute Coronary Syndrome Is Associated With a Marked Increase in Death and Myocardial Infarction at 30 days
Background:
Re-infarction (reMI) is associated with worse outcomes following fibrinolytic therapy and is increasingly a component of the primary endpoint in clinical trials In 2001, 3 large clinical trials reported that reMl was reduced in patients receiving the experimental reperfusion and adjunctive therapies.
In HERO-2, which randomized patients to receive either intravenous heparin or bivalirudin prior to streptokinase, reMl was adjudicated by a Cknical Endpoints Commrttee (CEC) and we report the results of reMl adjudication. Methods: Adjudication was performed on data collected by investigators according to the following pre-defined criteria: i) ~18 hours from randomization (230min chest pain and ZlmV ST elevation in 2 leads), ii) 18 hours from randomzation (CK level >2x upper limit of normal (ULN)or CKMB >ULN and >50% above prior baseline, iii) in association with percutaneous intervention (CK or CKMB levels z-3x ULN) or iv) Renal insufficiency (RI) is an established predictor of long-term outcome in patrents with coronary artery disease. The impact of RI on short-term outcomes following hospitalization for an acute coronary syndrome (ACS) remains unknown. We sought to investigate whether RI at the time of presentation with an ACS predicted clinical events at 30 days. Methods:
Using an interventional registry database, 504 patients presenting wrth an ACS were grouped into one of four categories based on creatinine clearance (CrCI) in mllmin: >90, 60-90, 30-60, and ~30. Patient outcomes were recorded at 30 days and 1 year. Results: Using a test of trend and homogeneity, we observed an exponential rise in the risk of death and Ml at 30 days for each decrement in renal function (X2=32, p~O.O000l)(graph).
Patients were then divided into two groups classified as normal (CrCIx60) 376A ABSTRACTS -Myocardial Ischemia and Infarction history of hypertension or heart failure, weigh less; were less likely to use tobacco, have a history of bypass surgery; and were less likely to undergo coronary revascularization.
(P<O.OOOl all). Increased time to revascularlzation. larger infarction size. and worse ejection fraction on discharge were more predictive of stroke in men than in women ( The mayor categories of the admitting diagnoses were pulmonary (eTnl = 8, nTnl = 9), sepsis (eTnl = 7, nTnl = l), neurological (eTnl = 6, nTnl = 9), gastrointestinal (eTnl = 7, nTnl = 6). and others (eTnl =2. nTnl = 5).
There were no significant differences found between the two groups in terms of their total number of cardiac risk factors, previous history of coronary artery disease or coronary revascularization, baseline creatinine, hematocrit, cholesterol levels, and use of aspirin, beta-blockers, angiotensin converting enzyme Inhibitors, or statins. The eTnl group consisted of 57% males, compared to 67% males in the nTnl group (p = 0.01). Mean age in the eTnl group was 67.8 years compared to 59.8 years in the nTnl group (p = 0.047). Of the thirty patients with elevated Trill (mean = 2.10 +/-0.52 SD), 12 (40%) died during index hospitalization as compared to zero deaths reported in patients with normal Tnl (mean = 0.04 +/-0.007 SD), and this dlfference was significant (PRR = 2.7, 95% Cl = 1.9-3.8, p < 0.0005). Despite differences in age and gender between the two groups, adjusted analysis revealed elevated Troponin I to be the only risk factor for mortality (p c 0.0005 for Tnl; p = 0.9 for gender; p = 0.8 for age). Conclusion:
We have shown for the first time that the elevated Tropomn I is an Independent prognostic marker for increased mortality even in the patients admitted with non-cardiac dlagnoses. There was a trend towards more patients with sepsis I" the elevated Troponin I group.
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Applying Evidence-Based Therapies in Clinical Practice Tuesday, April 01, 2003, 9: Delays in time to angioplasty after hospital arrival in patients (pts) undergoing primary PCI for AMI have been associated with increased mortality in large databases. However, the inherent reasons and correlates for delay to angioplasty remain poorly understood.
Methods:
We analyzed the baseline demographic, angiographic, and procedure-related variables predictive of delays in door-to-balloon time (DB time) in the CADILLAC trial, in which 2,082 pts of any age with AMI onset cl2 hours (excluding shock) were randomized to PTCA vs stew, with vs without abciximab. Predictors of delay to treatment after hospital arrival may be explained by atypical symptoms or indeterminate ECGs (female gender or LCX Ml), and less severe symptoms (smaller infarct vessel or patency of infarct vessel due to larger MLD). These data emphasize the need for awareness and expedited reperfusion pathways for patients at highest risk for delays to PCI.
Results
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